Head-to-head · free

Tenon Medical, Inc. vs Twist Bioscience

TNON vs TWST — return on capital, cash generation, margins and balance sheet side by side.

TNON

4 / 6

measures where TNON leads

TWST

2 / 6

measures where TWST leads

A simple count of which company scores better on each measure — not a recommendation to buy or sell.

MeasureTNON · FY2025TWST · FY2026
Revenue$3.9M—
Net income(12.6M)(130.2M)
Revenue growth (yearly, multi-year)78.7%—
Free cash flow(11.0M)(89.0M)
Free cash flow margin-279.4%—
Net cash / (debt)——
ROIC——
Return on equity-600.0%-16.4%
Gross margin59.8%50.7%
Operating margin-324.3%-36.2%
Net debt / EBITDA0.31x1.64x

Figures are as reported by each company; latest fiscal year shown.

Where Tenon Medical, Inc.'s cash went (FY2025)

Capital spending
$273000
Buybacks
—
Dividends
—
Acquisitions
—
Net debt issued / (repaid)
—
Full TNON profile →

Where Twist Bioscience's cash went (FY2026)

Capital spending
$47.6M
Buybacks
—
Dividends
—
Acquisitions
—
Net debt issued / (repaid)
—
Full TWST profile →

Ask which business is stronger

"Which one reinvests at higher returns?" "Who carries more risk in its filings?" Get answers drawn straight from both companies' filings.

Compare them free

More comparisons